Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
-1.1M
-
Total reported value, excl. options
-
$7.38M
-
Value change
-
-$659K
-
Number of buys
-
9
-
Number of sells
-
-17
-
Price
-
$0.48
Significant Holders of NextCure, Inc. - Common Stock (NXTC) as of Q1 2025
47 filings reported holding NXTC - NextCure, Inc. - Common Stock as of Q1 2025.
NextCure, Inc. - Common Stock (NXTC) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
of 28M outstanding shares and own 54.82% of the company stock.
Largest 10 shareholders include Sofinnova Investments, Inc. (2.67M shares), Affinity Asset Advisors, LLC (2.3M shares), Pfizer Inc (1.89M shares), CITIGROUP INC (1.42M shares), ORBIMED ADVISORS LLC (1.14M shares), VANGUARD GROUP INC (987K shares), Cable Car Capital, LP (670K shares), BlackRock, Inc. (557K shares), ACADIAN ASSET MANAGEMENT LLC (488K shares), and RENAISSANCE TECHNOLOGIES LLC (480K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.